XML 52 R35.htm IDEA: XBRL DOCUMENT v3.20.4
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Carrying Amount of Goodwill
Changes in the carrying amount of goodwill in 2020 and 2019 were as follows:
Codman Specialty SurgicalOrthopedics and Tissue TechnologiesTotal
 (In thousands)
Goodwill at January 1, 2019$625,760 $300,715 $926,475 
Arkis Acquisition
27,600 — 27,600 
Foreign currency translation140 65 205 
Goodwill at December 31, 2019$653,500 $300,780 $954,280 
Foreign currency translation18,475 7,158 25,633 
Transfer to assets held for sale (See Note 3. Assets Held for Sale)
$— $(47,546)$(47,546)
Goodwill at December 31, 2020$671,975 $260,392 $932,367 
Schedule of Components of Indefinite-Lived Intangible Assets
The components of the Company's identifiable intangible assets were as follows:
December 31, 2020
Weighted
Average
Life
CostAccumulated AmortizationNet
(Dollars in Thousands)
Completed technology
19 years
$896,478 $(248,088)$648,390 
Customer relationships
12 years
213,270 (132,838)80,432 
Trademarks/brand names
28 years
104,209 (31,767)72,442 
Codman trade nameIndefinite170,226 — 170,226 
Supplier relationships
27 years
30,211 (15,203)15,008 
All other (1)
4 years
9,995 (7,057)2,938 
$1,424,389 $(434,953)$989,436 

December 31, 2019
 Weighted
Average
Life
CostAccumulated AmortizationNet
 
 (Dollars in Thousands)
Completed technology
19 years
$880,623 $(213,702)$666,921 
Customer relationships
12 years
222,575 (119,393)103,182 
Trademarks/brand names
28 years
103,873 (28,514)75,359 
Codman trade name
Indefinite
163,126 — 163,126 
Supplier relationships
27 years
34,721 (17,947)16,774 
All other (1)
4 years
10,869 (4,640)6,229 
$1,415,787 $(384,196)$1,031,591 
(1)At December 31, 2020 and 2019, all other included IPR&D of $1.0 million, which was indefinite-lived. At December 31, 2020, this IPR&D asset was presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business which is expected to be sold within twelve months. See Note 3, Assets and Liabilities Held for Sale, for details.
Schedule of Components of Finite-Lived Intangible Assets
The components of the Company's identifiable intangible assets were as follows:
December 31, 2020
Weighted
Average
Life
CostAccumulated AmortizationNet
(Dollars in Thousands)
Completed technology
19 years
$896,478 $(248,088)$648,390 
Customer relationships
12 years
213,270 (132,838)80,432 
Trademarks/brand names
28 years
104,209 (31,767)72,442 
Codman trade nameIndefinite170,226 — 170,226 
Supplier relationships
27 years
30,211 (15,203)15,008 
All other (1)
4 years
9,995 (7,057)2,938 
$1,424,389 $(434,953)$989,436 

December 31, 2019
 Weighted
Average
Life
CostAccumulated AmortizationNet
 
 (Dollars in Thousands)
Completed technology
19 years
$880,623 $(213,702)$666,921 
Customer relationships
12 years
222,575 (119,393)103,182 
Trademarks/brand names
28 years
103,873 (28,514)75,359 
Codman trade name
Indefinite
163,126 — 163,126 
Supplier relationships
27 years
34,721 (17,947)16,774 
All other (1)
4 years
10,869 (4,640)6,229 
$1,415,787 $(384,196)$1,031,591 
(1)At December 31, 2020 and 2019, all other included IPR&D of $1.0 million, which was indefinite-lived. At December 31, 2020, this IPR&D asset was presented separately as "assets held for sale" in conjunction with the sale of the Extremity Orthopedics business which is expected to be sold within twelve months. See Note 3, Assets and Liabilities Held for Sale, for details.